Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

The relationship existing between heart failure (HF) and COVID-19 remains questioned and
poorly elucidated. Many reports suggest that HF events are reduced during pandemics …

With the onset of the COVID-19 pandemic, it became apparent that, in addition to pulmonary
infection, extrapulmonary manifestations such as cardiac injury and acute cerebrovascular …

Study objective To compare the characteristics and outcomes of COVID-19 patients with a
hyperdynamic LVEF (HDLVEF) to those with a normal or reduced LVEF. Design …

Abstract Coronavirus disease 2019 (COVID-19) has high infectivity and causes extensive
morbidity and mortality. Cardiovascular disease is a risk factor for adverse outcomes in …

Heart failure (HF) is a chronic, progressive, and inexorable syndrome affecting worldwide
billion of patients (equally distributed among men and women), with prevalence estimate of …

Aims Chronic heart failure (CHF) is a major risk factor for mortality in coronavirus disease
2019 (COVID‐19). This prospective international multicentre study investigates the role of …

The COVID pandemic has brought many new challenges worldwide, which has impacted on
patients with chronic conditions. There is an increasing evidence base suggesting an …

The purpose of this current opinion article is to illustrate a novel approach to the treatment of
acute decompensated heart failure (ADHF) in coronavirus disease 2019 (COVID-19) …